MedTrace Logo

The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER)

NCT03171311 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1201

Last updated 2026-05-18

No results posted yet for this study

Summary

The purpose is to compare median two-year clinical outcome after OCT guided vs. standard guided revascularization of patients requiring complex bifurcation stent implantation

Conditions

  • Ischaemic Heart Disease
  • Ischemic Heart Disease

Interventions

PROCEDURE

Angiographic guided PCI

Angiographic guided PCI is percutaneous coronary intervention performed by standard angiographic guided techniques

PROCEDURE

OCT guided PCI

OCT guided PCI is percutaneous coronary intervention (PCI) guided by intra vascular optical coherence tomography (OCT) scans

Sponsors & Collaborators

  • Abbott

    collaborator INDUSTRY

  • Aarhus University Hospital Skejby

    lead OTHER

Principal Investigators

  • Evald H Christiansen, MD, PhD · Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-05
Primary Completion
2022-03-25
Completion
2029-05-31

Countries

  • Belgium
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Ireland
  • Italy
  • Latvia
  • Netherlands
  • Norway
  • Poland
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03171311 on ClinicalTrials.gov